Nonresponders For all current vaccines, there is a significant population of individuals who are considered nonresponders (i.e., nonseroconverters), particularly those with an inability to mount effective B-cell responses
NHS access requires meeting NICE eligibility criteria, specialist or enhanced GP assessment, and demonstration of metabolic response (HbA1c reduction 11 mmol/mol and 3% weight loss) at six months
Moreover, it has been recently summarized that, like apoptosis and necroptosis in nucleated cells [26], eryptosis and erythronecroptosis are mutually exclusive [28]
Wegovy has longer-term cardiovascular outcomes data from the SELECT trial [4]
Following overinvestment during the pandemic, Pfizer is reducing costs to adapt to the slowing demand for covid products